Feb. 17, 2021—Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19.
Feb. 17, 2021—Assistant Professor of Molecular Physiology and Biophysics Gregor Neuert and Assistant Professor of Biochemistry Yi Ren have been recognized as School of Medicine Basic Sciences Dean’s Faculty Fellows. Established in 2020, the Dean’s Faculty Fellows program in Basic Sciences is designed to recognize the efforts of faculty in the early stages of their career.
Dec. 18, 2020—Moderna, remdesivir, AstraZeneca. VUMC’s experts have played an integral role in the development of these marquee COVID-19 therapeutics behind the scenes.
Nov. 9, 2020—Yi Ren, assistant professor of biochemistry, has contributed to research on the function and impact of the SARS-CoV-2 protein on immune signaling protein in host cells. This understanding may lead to the development of immune-enhancing therapeutics.
Nov. 6, 2020—Assistant Professor of Biochemistry Yi Ren and her team have made several discoveries to illuminate the mechanisms of key host-pathogen interactions involving viruses, with implications for gaining a better understanding of SARS-CoV-2, the virus that causes COVID-19.
Apr. 8, 2020—New insights on influenza genome packaging could guide strategies for interfering with the virus's life cycle and ability to cause infection.